Corvus Pharma (CRVS.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov5

Corvus Pharma released FY2025 9 Months Earnings on November 4 After-Market EST with actual revenue of USD 0 and EPS of USD -0.3576

00:00

Corvus Pharma released FY2025 Q3 earnings on November 4 After-Market EST, actual revenue USD 0 (forecast USD 0), actual EPS USD -0.1226 (forecast USD -0.1295)

00:00

Nov4

Corvus Pharmaceuticals Reports Improved Net Loss in Q3 2025, soquelitinib Development Progresses Smoothly

21:03

Oct28

Corvus Pharma to Release FY2025 Q3 Earnings on November 4 After-Market EST, Forecast Revenue USD 0, EPS USD -0.1295

00:06

Aug7

Corvus Pharma released FY2025 Semi-Annual Earnings on August 7 After-Market (EST), Actual Revenue: USD 0, Actual EPS: USD -0.2606

23:00

Corvus Pharma released FY2025 Q2 earnings on August 7 After-Market EST, actual revenue USD 0 (forecast USD 0), actual EPS USD -0.1028 (forecast USD -0.1333)

23:00